IGF1 and Alzheimer disease: According to AUC analysis of test set and validation of training sets, cohort subgroup comparisons revealed that low IGF1 could actually distinguish AD from non-dementia controls, indicating IGF1 to be a molecular target in predicting the onset of AD.